Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay

Journal of Clinical Microbiology

Volumn 41, Issue 10, 2003, Pages 4817-4819

  Favre, Bertrand ^a,c   Hofbauer, Bettina ^a   Hildering, Kwang Soo ^a,d   Ryder, Neil S ^a,b  

^a NOVARTIS RESEARCH INSTITUTE   (Austria)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Igeneon AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

10 UNDECENOIC ACID; AMOROLFINE; ANTIFUNGAL AGENT; BUTENAFINE; CICLOPIROXOLAMINE; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NAFTIFINE; TERBINAFINE; TIOCONAZOLE; TOLCICLATE; TOLNAFTATE; VORICONAZOLE;

ARTICLE; DERMATOPHYTE; DRUG ACTIVITY; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM CANIS; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DERMATOMYCOSES; HUMANS; MICROBIAL SENSITIVITY TESTS;

ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; ARTHRODERMATACEAE; CANIS; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM; MICROSPORUM CANIS; TRICHOPHYTON; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 0141923761     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.10.4817-4819.2003     Document Type: Article

References (25)

1. Barchiesi, F., D. Arzeni, V. Camiletti, O. Simonetti, A. Cellini, A. M. Offidani, and G. Scalise. 2001. In vitro activity of posaconazole against clinical isolates of dermatophytes. J. Clin. Microbiol. 39:4208-4209.
2. Del Rosso, J. Q. 2000. Current management of onychomycosis and dermatomycoses. Curr. Infect. Dis. Rep. 2:438-445.
3. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
4. Espinel-Ingroff, A., A. Fothergill, J. Peter, M. G. Rinaldi, and T. J. Walsh. 2002. Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J. Clin. Microbiol. 40:3204-3208.
5. Fernandez-Torres, B., A. J. Carrillo, E. Martin, A. Del Palacio, M. K. Moore, A. Valverde, M. Serrano, and J. Guarro. 2001. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob. Agents Chemother. 45:2524-2528.
6. Fernandez-Torres, B., H. Vazquez-Veiga, X. Llovo, M. Pereiro, Jr., and J. Guarro. 2000. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 46:390-394.
7. Georgopoulos, A. 1978. Deep-freeze preservation of fungi in liquid nitrogen as a basis for standardized inocula. Mykosen 21:19-23. (In German.)
8. Gupta, A. K., P. Adam, N. Dlova, C. W. Lynde, S. Hofstader, N. Morar, J. Aboobaker, and R. C. Summerbell. 2001. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr. Dermatol. 18:433-438.
9. Hazen, K. C. 1998. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J. Am. Acad. Dermatol. 38:S37-S41.
10. Hazen, K. C. 2000. Evaluation of in vitro susceptibility of dermatophytes to oral antifungal agents. J. Am. Acad. Dermatol. 43:125-129.
11. Hofbauer, B., I. Leitner, and N. S. Ryder. 2002. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin. Med. Mycol. 40:1-5.
12. Jessup, C. J., N. S. Ryder, and M. A. Ghannoum. 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol. 38:155-159.
13. Jessup, C. J., J. Warner, N. Isham, I. Hasan, and M. A. Ghannoum. 2000. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J. Clin. Microbiol. 38:341-344.
14. Korting, H. C., M. Ollert, and D. Abeck. 1995. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob. Agents Chemother. 39:1206-1208.
15. Manavathu, E. K., J. Cutright, and P. H. Chandrasekar. 1999. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J. Clin. Microbiol. 37:858-861.
16. Moore, C. B., D. Law, and D. W. Denning. 1993. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp. J. Antimicrob. Chemother. 32:831-836.
17. National Committee for Clinical Laboratory Standards. 2000. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Niewerth, M., V. Splanemann, H. C. Korting, J. Ring, and D. Abeck. 1998. Antimicrobial susceptibility testing of dermatophytes-comparison of the agar macrodilution and broth microdilution tests. Chemotherapy 44:31-35.
19. Nimura, K., Y. Niwano, S. Ishiduka, and R. Fukumoto. 2001. Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan. Int. J. Antimicrob. Agents 18:173-178.
20. Norris, H. A., B. E. Elewski, and M. A. Ghannoum. 1999. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J. Am. Acad. Dermatol. 40:S9-S13.
21. Perea, S., A. W. Fothergill, D. A. Sutton, and M. G. Rinaldi. 2001. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J. Clin. Microbiol. 39:385-388.
22. Pujol, I., C. Aguilar, J. Fernandez-Ballart, and J. Guarro. 2000. Comparison of the minimum fungicidal concentration of amphotericin B determined in filamentous fungi by macrodilution and microdilution methods. Med. Mycol. 38:23-26.
23. Roberts, D. T. 1999. Onychomycosis: current treatment and future challenges. Br. J. Dermatol. 141(Suppl. 56):1-4.
24. Tawara, S., F. Ikeda, K. Maki, Y. Morishita, K. Otomo, N. Teratani, T. Goto, M. Tomishima, H. Ohki, A. Yamada, K. Kawabata, H. Takasugi, K. Sakane, H. Tanaka, F. Matsumoto, and S. Kuwahara. 2000. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob. Agents Chemother. 44:57-62.
25. Wildfeuer, A., H. P. Seidl, I. Paule, and A. Haberreiter. 1998. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41:309-319.